A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction

The incidence of breast reconstruction failure after conventional photon radiotherapy for breast cancer is about 18.7%. At present, there is limited data on proton radiotherapy for post operative breast cancer with implantation reconstruction. Proton radiotherapy for breast cancer can significantly reduce the radiation dose of the ipsilateral heart and lung, thereby reducing the incidence of cardiac events and radiation pneumonia. This study is aimed at the study of adjuvant hypofractionated intensity-modulated proton radiotherapy for post operative breast cancer with implantation reconstructi

Trial Details

NCT ID

NCT05692674

Phase

PHASE2

Sponsor

Shanghai Proton and Heavy Ion Center

Status

RECRUITING

Cancer Type

Breast Cancer

Interventions

• adjuvant hypofractionated intensity-modulated proton radiotherapy

Locations (sample)

• Shanghai, Shanghai Municipality, China|31.22222,121.45806

Key Eligibility Criteria

• 1: Patients with pathologically confirmed breast cancer
• 2: Indications: patients who need adjuvant radiotherapy after mastectomy and implant reconstruction
• 3: No distant metastasis
• 4: Had no chest and breast radiotherapy history

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →